← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Organigram Global Inc. (OGI) 10-Year Financial Performance & Capital Metrics

OGI • • Industrial / General
HealthcareSpecialty & Generic PharmaCannabis & Hemp ProductsRecreational Cannabis Brands
AboutOrganigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.Show more
  • Revenue $186M +16.4%
  • EBITDA -$50M -114.1%
  • Net Income -$18M +60.9%
  • EPS (Diluted) -0.14 +70.8%
  • Gross Margin 3.67% -87.7%
  • EBITDA Margin -27.14% -83.9%
  • Operating Margin -34.07% -52.7%
  • Net Margin -9.55% +66.4%
  • ROE -6.39% +59.4%
  • ROIC -23.59% -96.3%
  • Debt/Equity 0.03 +139.8%
  • Interest Coverage -
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong 5Y sales CAGR of 16.5%
  • ✓Trading at only 0.8x book value

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 34.0% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y68.87%
5Y16.48%
3Y8.47%
TTM16.42%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM45.51%

EPS CAGR

10Y-
5Y-
3Y-
TTM75.3%

ROCE

10Y Avg-14.94%
5Y Avg-24.1%
3Y Avg-30.74%
Latest-20.06%

Peer Comparison

Recreational Cannabis Brands
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
CRONCronos Group Inc.991.69M2.5923.5534.82%27.27%3.19%0.57%0.00
CGCCanopy Growth Corporation460.99M1.22-0.22-9.47%-138.49%-52.42%0.72
SNDLSNDL Inc.417.15M1.62-4.301.26%-9.7%-8.39%10.52%0.13
OGIOrganigram Global Inc.213.79M1.59-11.3616.42%-13.3%-9.88%0.03

Profit & Loss

Aug 2016Aug 2017Aug 2018Aug 2019Aug 2020Aug 2021Aug 2022Sep 2023Sep 2024Sep 2025
Sales/Revenue+6.13M5.39M12.43M80.41M86.8M79.16M145.81M149.21M159.84M186.09M
Revenue Growth %5.21%-0.12%1.31%5.47%0.08%-0.09%0.84%0.02%0.07%0.16%
Cost of Goods Sold+813.38K8.69M-39.2M31.94M143.28M107.56M114.24M114.13M112.32M179.26M
COGS % of Revenue0.13%1.61%-3.15%0.4%1.65%1.36%0.78%0.76%0.7%0.96%
Gross Profit+5.31M-3.3M-26.77M48.47M-56.49M-28.4M31.57M35.07M47.52M6.83M
Gross Margin %0.87%-0.61%-2.15%0.6%-0.65%-0.36%0.22%0.24%0.3%0.04%
Gross Profit Growth %7.21%-1.62%-7.12%2.81%-2.17%0.5%2.11%0.11%0.36%-0.86%
Operating Expenses+4.07M7.8M15.22M42.37M89.02M63.42M74.72M271.48M83.19M70.24M
OpEx % of Revenue0.66%1.45%1.22%0.53%1.03%0.8%0.51%1.82%0.52%0.38%
Selling, General & Admin4.07M7.39M15.22M41.3M46.47M46.47M59.21M71.68M68.14M86.88M
SG&A % of Revenue0.66%1.37%1.22%0.51%0.54%0.59%0.41%0.48%0.43%0.47%
Research & Development000409K1.27M3.45M5.96M12.19M11.2M10.95M
R&D % of Revenue---0.01%0.01%0.04%0.04%0.08%0.07%0.06%
Other Operating Expenses0410K0664K-6.37M-5.53M5.14M193.95M3.85M-27.59M
Operating Income+1.25M-11.1M36.42M5.49M-145.51M-91.82M-43.15M-242.74M-35.67M-63.41M
Operating Margin %0.2%-2.06%2.93%0.07%-1.68%-1.16%-0.3%-1.63%-0.22%-0.34%
Operating Income Growth %2.08%-9.91%4.28%-0.85%-27.52%0.37%0.53%-4.63%0.85%-0.78%
EBITDA+2.03M-9.54M39.94M14.39M-127.55M-60.79M-18.24M-219.31M-23.59M-50.5M
EBITDA Margin %0.33%-1.77%3.21%0.18%-1.47%-0.77%-0.13%-1.47%-0.15%-0.27%
EBITDA Growth %3.73%-5.7%5.18%-0.64%-9.86%0.52%0.7%-11.02%0.89%-1.14%
D&A (Non-Cash Add-back)785.59K1.56M3.53M8.9M17.96M31.03M24.91M23.43M12.08M12.91M
EBIT1.28M-10.55M37.87M3.79M-140.62M-127.74M-13.94M-48.79M-35.67M-27.66M
Net Interest Income+-436K-264K-10.09M-9.67M-6.01M-2.96M-429K3.41M0825.7K
Interest Income00000003.69M0825.7K
Interest Expense436.37K264K10.09M9.67M6.01M2.96M429K277.85K00
Other Income/Expense-399K288K-8.64M-11.36M-1.12M-38.88M28.78M-184.21M-9.77M35.74M
Pretax Income+846.66K-10.81M27.78M-5.88M-146.63M-130.7M-14.37M-233M-45.44M-27.66M
Pretax Margin %0.14%-2.01%2.23%-0.07%-1.69%-1.65%-0.1%-1.56%-0.28%-0.15%
Income Tax+005.65M3.63M-10.47M0-88K-3.52M0-9.89M
Effective Tax Rate %1%1.01%0.74%1.62%0.93%1%0.99%0.98%1%0.64%
Net Income+846.66K-10.89M20.51M-9.54M-136.16M-130.7M-14.28M-229.48M-45.44M-17.78M
Net Margin %0.14%-2.02%1.65%-0.12%-1.57%-1.65%-0.1%-1.54%-0.28%-0.1%
Net Income Growth %1.66%-13.86%2.88%-1.47%-13.27%0.04%0.89%-15.07%0.8%0.61%
Net Income (Continuing)846.66K-10.81M22.12M-9.5M-136.16M-130.7M-14.28M-229.48M-45.44M-17.78M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)+0.06-0.450.65-0.27-3.15-2.04-0.18-2.82-0.48-0.14
EPS Growth %1.59%-8.8%2.44%-1.42%-10.67%0.35%0.91%-14.67%0.83%0.71%
EPS (Basic)0.06-0.450.68-0.27-3.15-2.04-0.18-2.82-0.48-0.14
Diluted Shares Outstanding14.67M24.3M31.71M35.23M43.17M64.03M85.3M81.29M95.29M127.67M
Basic Shares Outstanding14.67M24.3M30.14M35.23M43.17M64.03M80.01M81.29M95.29M127.67M
Dividend Payout Ratio----------

Balance Sheet

Aug 2016Aug 2017Aug 2018Aug 2019Aug 2020Aug 2021Aug 2022Sep 2023Sep 2024Sep 2025
Total Current Assets+40.65M44.67M203.21M196.28M170.2M260.62M221.62M155.98M262.22M204.56M
Cash & Short-Term Investments32.63M33.96M130.06M47.94M74.73M183.84M98.91M33.86M107.57M60.61M
Cash Only9.86M1.96M55.06M47.55M24.6M55.37M68.52M33.86M106.75M60.02M
Short-Term Investments22.77M32M75M380K50.13M128.48M30.4M0821K593.07K
Accounts Receivable1.56M1.01M793K11.63M16.98M21M46.37M27.46M37.15M46.57M
Days Sales Outstanding93.0368.223.2952.871.3996.81116.0867.1784.8491.34
Inventory6.31M5.41M64.83M113.8M71.76M48.82M68.28M80.95M82.52M123.95M
Days Inventory Outstanding2.83K227.16-603.561.3K182.8165.66218.16258.89268.18252.38
Other Current Assets03.58M1.22M5.82M002.21M13.7M25.86M-38.24M
Total Non-Current Assets+13.22M48.14M99.35M232.24M247.42M293.4M355.48M142.48M145.64M199.11M
Property, Plant & Equipment13.22M45.35M98.64M219.05M247.42M235.94M259.82M99.05M96.23M122.98M
Fixed Asset Turnover0.46x0.12x0.13x0.37x0.35x0.34x0.56x1.51x1.66x1.51x
Goodwill02.33M00014.32M41.98M0037.71M
Intangible Assets0001.5M1.77M2.73M14.26M10.62M8.09M34.83M
Long-Term Investments00011.11M7M6.11M7.07M13.72M40.73M35.58M
Other Non-Current Assets0467.49K714K592K8.03M31.11M32.36M19.09M591K-31.98M
Total Assets+53.87M92.81M302.57M428.52M417.62M554.02M577.11M298.45M407.86M403.67M
Asset Turnover0.11x0.06x0.04x0.19x0.21x0.14x0.25x0.50x0.39x0.46x
Asset Growth %2.8%0.72%2.26%0.42%-0.03%0.33%0.04%-0.48%0.37%-0.01%
Total Current Liabilities+2.45M6.65M11.25M43.86M29.08M26.27M55.28M22.43M53.32M126.16M
Accounts Payable2.12M6.26M10.76M40.35M17.49M18.95M40.86M14.73M47.1M64.08M
Days Payables Outstanding949.18263.01-100.22461.1144.5464.31130.5647.1153.05130.47
Short-Term Debt330.65K389.82K421K3.51M11.6M80K80K76K60K25K
Deferred Revenue (Current)000-1000K001000K000
Other Current Liabilities0-65965K006.25M12M2.35M5.14M61.08M
Current Ratio16.62x6.72x18.06x4.47x5.85x9.92x4.01x6.95x4.92x1.62x
Quick Ratio14.04x5.91x12.30x1.88x3.39x8.06x2.77x3.34x3.37x0.64x
Cash Conversion Cycle1.97K32.35-480.05891.95209.64198.16203.68278.96199.97213.25
Total Non-Current Liabilities+7.16M3.13M106.72M57.66M89.02M47.95M13.76M4.4M48.55M86.92M
Long-Term Debt7.16M3.13M98.74M46.07M103.67M230K155K3.63M25K0
Capital Lease Obligations00002.62M4.65M2.21M03.34M7.75M
Deferred Tax Liabilities007.98M10.47M003.62M000
Other Non-Current Liabilities0510011.59M-17.27M43.06M7.79M771K45.18M79.17M
Total Liabilities9.61M9.78M117.97M101.52M118.1M74.21M69.05M26.83M101.87M152.99M
Total Debt+7.49M3.52M99.16M49.58M103.67M5.95M3.36M3.71M4.46M8.75M
Net Debt-2.37M1.56M44.1M2.02M79.07M-49.42M-65.16M-30.16M-102.29M-53.74M
Debt / Equity0.17x0.04x0.54x0.15x0.35x0.01x0.01x0.01x0.01x0.03x
Debt / EBITDA3.69x-2.48x3.45x------
Net Debt / EBITDA-1.16x-1.10x0.14x------
Interest Coverage2.86x-42.05x3.61x0.57x-24.22x-31.02x-100.59x-873.64x--
Total Equity+44.26M83.03M184.59M327.01M299.53M479.81M508.06M271.62M305.99M250.68M
Equity Growth %4.64%0.88%1.22%0.77%-0.08%0.6%0.06%-0.47%0.13%-0.18%
Book Value per Share3.023.425.829.286.947.495.963.343.211.96
Total Shareholders' Equity44.26M83.03M184.59M327.01M299.53M479.81M508.06M271.62M305.99M250.68M
Common Stock50.96M99.7M157.79M318.13M420.67M730.8M769.73M776.91M852.89M660.49M
Retained Earnings-8.87M-19.75M759K-8.78M-144.94M-275.64M-289.93M-538.53M-583.97M-437.07M
Treasury Stock0000000000
Accumulated OCI2.17M3.08M26.05M17.66M23.79M24.65M28.26M33.24M37.07M27.25M
Minority Interest0000000000

Cash Flow

Aug 2016Aug 2017Aug 2018Aug 2019Aug 2020Aug 2021Aug 2022Sep 2023Sep 2024Sep 2025
Cash from Operations+-1.77M-6.11M-12.7M-35.08M-45.13M-28.59M-36.21M-35.8M3.87M-4.3M
Operating CF Margin %-0.29%-1.13%-1.02%-0.44%-0.52%-0.36%-0.25%-0.24%0.02%-0.02%
Operating CF Growth %0.36%-2.45%-1.08%-1.76%-0.29%0.37%-0.27%0.01%1.11%-2.11%
Net Income846.66K-10.89M22.12M-9.5M-136.16M-130.7M-14.28M-229.48M-45.44M-24.76M
Depreciation & Amortization785.59K1.55M3.53M8.9M17.96M31.03M24.91M24.08M12.08M17.98M
Stock-Based Compensation442.35K2.21M5.03M14.89M7.8M3.9M5.13M5.29M7.18M4.22M
Deferred Taxes-37.41K-102.81K-1.86M3.63M-10.47M42.21M-88K00-13.77M
Other Non-Cash Items154.19K625.14K-643K4.01M46.71M776K-29M151.8M15.09M14.16M
Working Capital Changes-3.96M494.43K-40.88M-57.02M29.04M24.2M-22.88M12.51M14.96M-2.12M
Change in Receivables-795.11K-2.42M337K-13.13M1.79M-6.01M-24.02M12.51M-12.06M-15.29M
Change in Inventory-3.74M550.6K-48.68M-40.91M45.64M28.68M-12.22M000
Change in Payables652.07K3.89M3.98M10.56M-28M2.06M12.15M000
Cash from Investing+-27.15M-42.6M-98M-46.78M-138.2M-115.11M44.03M4.56M-38.77M-59.35M
Capital Expenditures-4.42M-34.33M-56.44M-110.29M-78.65M-12.33M-48.78M-26.9M-4.73M-17.02M
CapEx % of Revenue0.72%6.37%4.54%1.37%0.91%0.16%0.33%0.18%0.03%0.09%
Acquisitions----------
Investments----------
Other Investing400294.16K-17K621K-8.64M-31.07M4.29M31.46M-8.32M21.8M
Cash from Financing+37.31M40.81M163.91M74.33M160.37M174.46M5.33M-754.15K107.78M28.24M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-2.92M2.33M-8.36M28.15M-2.97M5.99M6.34M-754.15K6K-1.29M
Net Change in Cash----------
Free Cash Flow+-6.19M-40.44M-69.14M-145.38M-123.78M-40.92M-84.99M-62.7M-1.47M-16.52M
FCF Margin %-1.01%-7.5%-5.56%-1.81%-1.43%-0.52%-0.58%-0.42%-0.01%-0.09%
FCF Growth %0.4%-5.53%-0.71%-1.1%0.15%0.67%-1.08%0.26%0.98%-10.27%
FCF per Share-0.42-1.66-2.18-4.13-2.87-0.64-1.00-0.77-0.02-0.13
FCF Conversion (FCF/Net Income)-2.09x0.56x-0.62x3.68x0.33x0.22x2.54x0.16x-0.09x0.24x
Interest Paid0000000000
Taxes Paid0000000000

Key Ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)3.25%-17.11%15.33%-3.73%-43.46%-33.54%-2.89%-58.86%-15.73%-6.39%
Return on Invested Capital (ROIC)3.52%-13.16%17.44%1.48%-30.84%-17.03%-7.41%-53.2%-12.02%-23.59%
Gross Margin86.72%-61.18%-215.42%60.28%-65.08%-35.87%21.65%23.51%29.73%3.67%
Net Margin13.82%-202.08%165.04%-11.87%-156.87%-165.11%-9.8%-153.8%-28.43%-9.55%
Debt / Equity0.17x0.04x0.54x0.15x0.35x0.01x0.01x0.01x0.01x0.03x
Interest Coverage2.86x-42.05x3.61x0.57x-24.22x-31.02x-100.59x-873.64x--
FCF Conversion-2.09x0.56x-0.62x3.68x0.33x0.22x2.54x0.16x-0.09x0.24x
Revenue Growth521.08%-12.06%130.64%546.98%7.94%-8.79%84.19%2.33%7.13%16.42%

Revenue by Segment

20202021202220242025
International Business To Business3.27M386K15.14M9.65M26.34M
International Business To Business Growth--88.20%3821.76%-36.25%172.88%
Wholesale To Licensed Producers Revenue15.18M2.06M1.3M5.31M9.36M
Wholesale To Licensed Producers Revenue Growth--86.43%-36.99%309.09%76.20%
Direct To Patient Medical Revenue10.75M8.7M7.87M1.73M2.4M
Direct To Patient Medical Revenue Growth--19.05%-9.53%-78.00%38.57%
Other Revenue245K202K115K97K142K
Other Revenue Growth--17.55%-43.07%-15.65%46.39%
Adult Use Recreational Wholesale Revenue73.94M98.51M184.69M--
Adult Use Recreational Wholesale Revenue Growth-33.23%87.48%--

Frequently Asked Questions

Growth & Financials

Organigram Global Inc. (OGI) reported $186.1M in revenue for fiscal year 2025.

Organigram Global Inc. (OGI) grew revenue by 16.4% over the past year. This is strong growth.

Organigram Global Inc. (OGI) reported a net loss of $24.8M for fiscal year 2025.

Dividend & Returns

Organigram Global Inc. (OGI) has a return on equity (ROE) of -6.4%. Negative ROE indicates the company is unprofitable.

Organigram Global Inc. (OGI) had negative free cash flow of $24.3M in fiscal year 2025, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.